ZH
RU
ES
medicines and drugs
medicines and drugs, Total:32 items.
In the international standard classification, medicines and drugs involves: Pharmaceutics, Applications of information technology, Vocabularies.
American Society for Testing and Materials (ASTM), medicines and drugs
- ASTM E2537-08 Standard Guide for Application of Continuous Quality Verification to Pharmaceutical and Biopharmaceutical Manufacturing
- ASTM E2500-07(2012) Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
- ASTM E2363-23 Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
- ASTM E3051-16 Standard Guide for Specification, Design, Verification, and Application of Single-Use Systems in Pharmaceutical and Biopharmaceutical Manufacturing
American National Standards Institute （ANSI), medicines and drugs
ET-QSAE, medicines and drugs
US-CFR-file, medicines and drugs
- CFR 21-316.3-2013 Food and drugs. Part316:Orphan drugs. Section316.3:Definitions.
- CFR 21-316.26-2013 Food and drugs. Part316:Orphan drugs. Section316.26:Amendment to orphan-drug designation.
- CFR 21-316.28-2013 Food and drugs. Part316:Orphan drugs. Section316.28:Publication of orphan-drug designations.
- CFR 21-316.29-2013 Food and drugs. Part316:Orphan drugs. Section316.29:Revocation of orphan-drug designation.
- CFR 21-316.4-2013 Food and drugs. Part316:Orphan drugs. Section316.4:Address for submissions.
- CFR 21-316.50-2013 Food and drugs. Part316:Orphan drugs. Section316.50:Guidance documents.
- CFR 21-316.21-2013 Food and drugs. Part316:Orphan drugs. Section316.21:Verification of orphan-drug status.
- CFR 21-316.25-2013 Food and drugs. Part316:Orphan drugs. Section316.25:Refusal to grant orphan-drug designation.
- CFR 21-316.24-2013 Food and drugs. Part316:Orphan drugs. Section316.24:Deficiency letters and granting orphan-drug designation.
- CFR 21-316.31-2013 Food and drugs. Part316:Orphan drugs. Section316.31:Scope of orphan-drug exclusive approval.
- CFR 21-316.1-2013 Food and drugs. Part316:Orphan drugs. Section316.1:Scope of this part.
- CFR 21-316.22-2013 Food and drugs. Part316:Orphan drugs. Section316.22:Permanent-resident agent for foreign sponsor.
- CFR 21-316.34-2013 Food and drugs. Part316:Orphan drugs. Section316.34:FDA recognition of exclusive approval.
- CFR 21-316.20-2013 Food and drugs. Part316:Orphan drugs. Section316.20:Content and format of a request for orphan-drug designation.
- CFR 21-558.205-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.205:Dichlorvos.
- CFR 21-558.195-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.195:Decoquinate.
- CFR 21-558.366-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.366:Nicarbazin.
- CFR 21-558.618-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.618:Tilmicosin.
- CFR 21-558.665-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.665:Zilpaterol.
- CFR 21-316.23-2013 Food and drugs. Part316:Orphan drugs. Section316.23:Timing of requests for orphandrug designation; designation of already approved drugs.
- CFR 21-558.500-2013 Food and drugs. Part558:New animal drugs for use in animal feeds. Section558.500:Ractopamine.
- CFR 21-514.11-2014 Food and drugs. Part514:New animal drug applications. Section514.11:Confidentiality of data and information in a new animal drug application file.
Professional Standard - Agriculture, medicines and drugs